Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/Atorvastatin in Heterozygous Familial Hypercholesterolemia
NCT00134485Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of torcetrapib in heterozygous familial hypercholesterolemia (HeFH), sponsored by Pfizer. Started Mar 2005; status: completed.
02
Drugs
torcetrapib
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT00134485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134485.